Human Apolipoprotein E,Apo-E ELISA Kit
- Known as:
- Human Apolipoprotein E,Apo-E Enzyme-linked immunosorbent assay test Kit
- Catalog number:
- 201-12-1452
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Sunredbio SunBT Sun red bio
- Gene target:
- Human Apolipoprotein Apo- ELISA Kit
Ask about this productRelated genes to: Human Apolipoprotein E,Apo-E ELISA Kit
- Gene:
- APOM NIH gene
- Name:
- apolipoprotein M
- Previous symbol:
- -
- Synonyms:
- ApoM, G3a, NG20
- Chromosome:
- 6p21.33
- Locus Type:
- gene with protein product
- Date approved:
- 2002-08-02
- Date modifiied:
- 2016-10-05
- Gene:
- TNFRSF10A NIH gene
- Name:
- TNF receptor superfamily member 10a
- Previous symbol:
- -
- Synonyms:
- DR4, Apo2, TRAILR-1, CD261, TRAILR1
- Chromosome:
- 8p21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1998-12-04
- Date modifiied:
- 2018-01-25
- Gene:
- TNFSF10 NIH gene
- Name:
- TNF superfamily member 10
- Previous symbol:
- -
- Synonyms:
- TRAIL, Apo-2L, TL2, CD253
- Chromosome:
- 3q26
- Locus Type:
- gene with protein product
- Date approved:
- 1998-12-04
- Date modifiied:
- 2017-03-02
Related products to: Human Apolipoprotein E,Apo-E ELISA Kit
Related articles to: Human Apolipoprotein E,Apo-E ELISA Kit
- The occurrence and development of atherosclerosis (AS) are closely related to disorders of lipid metabolism and dysfunction of autophagy. However, the key regulatory genes and immune microenvironment characteristics require further exploration. - Source: PubMed
Li MinSun YanjunSun YanyiChen Zhenyue - Clear cell renal cell carcinoma (ccRCC) is the most common and aggressive subtype of kidney cancer. Loss of von Hippel-Lindau (VHL) and the consequent activation of hypoxia-inducible factor-α (HIFα, especially HIF2α) plays an essential role in ccRCC initiation and progression. The VHL-HIF2α axis as the main driver for ccRCC may present specific opportunities to control the disease by cotargeting HIF2α with belzutifan and another vulnerability. This study elucidates the synthetic essentiality of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) in VHL-deficient ccRCC. Upregulated in ccRCC in a VHL-HIF2α-dependent manner, TRAIL is selectively essential in ccRCC cells, promoting cell proliferation by activating the p38 MAPK pathway and facilitating G1/S phase transition. Depletion of endogenous TRAIL or inhibition of HIF2α with belzutifan sensitizes ccRCC cell and tumor models to recombinant TRAIL, presenting a promising avenue for combination therapy in ccRCC. - Source: PubMed
Publication date: 2026/07/01
Wang XuechunQin YujingDuong Loan DLiang MinzhiChao AdrianParrotta RossellaLi YaoyinPurohit Paresh KumarFang YihaoLiu GuoqiangHe JianpingWen JilingLiu YanZhang YutingZhao JunlingBarupala NipuniSchafer Zachary TLu XueminSzegezdi EvaLu Xin - Dry age-related macular degeneration (AMD) is characterized by progressive degeneration of the retinal pigment epithelium-choroid interface, accompanied by immune dysregulation. However, the cellular interactions and regulatory mechanisms driving macrophage activation in this process remain incompletely understood. - Source: PubMed
Publication date: 2026/06/16
Chen YujieLiu ChulingChen JinghanHuang YiminPan GuipingWang PanHu YishanChen LinZhang YuxiWang Yan - The interaction between HIV-1 and the host immune system plays a crucial role in the natural control and progression of the infection. Previous studies have identified APOBEC3G, Tetherin, SAMHD1, and SERINC5 as HIV-1 host restriction factors, which are counteracted by the viral proteins Vif, Vpu, and Nef, respectively. The blood expression levels of some of these host proteins are correlated with HIV load, suggesting that interindividual differences in the spontaneous control of HIV infection might lead to the identification of novel HIV restriction factors. Our study enrolled 150 participants from the Swiss HIV Cohort Study with human genome-wide genotyping data, pre-antiretroviral treatment peripheral blood mononuclear cells (PBMC) aliquots and HIV load measurements. - Source: PubMed
Publication date: 2026/06/16
Oreshkov SergeyThorball Christian WMeylan JennyMuriset MaudeCalmy AlexandraCiuffi AngelaElzi LuigiaNemeth JohannesMuhammad AnsarBaumann LukasSchmid PatrickStöckle MarcelAlpern Daniel Fellay JacquesSantoni Federico - Gentiopicroside (GPS) has reported anti-inflammatory and neuroprotective effects. This research aimed to explore the reparative impacts and molecular mechanisms of GPS on brain injury in acute phase of middle cerebral artery occlusion (MCAO). - Source: PubMed
Publication date: 2026/05/21
Kui LingWang GuoyunZhang LiLiao QifengLi XiWang ShuangshuangChen TaoLeng BingfengHuang JinqunJiao YinmingYe QiaoyuanZeng QingqianXiong Kexu